Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
Clinical trial NCT02079246 · COMPLETED
Trial details
- NCT number
- NCT02079246
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-07
- Primary completion
- 2017-07-06
- Enrollment
- 1463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.